Needle Exchange Programs: Benefits and Challenges
Featuring remarks by Vice Adm. Jerome M. Adams, MD, MPH, Surgeon General of the United States.
Followed by a discussion with Ricky Bluthenthal, PhD, Professor of Preventive Medicine and Associate Dean for Social Justice, University of Southern California Keck School of Medicine; Hon. Tony Rivero, Arizona State Representative (R‐21st District); moderated by Jeffrey A. Singer, MD, Senior Fellow, Cato Institute.
Join the conversation on Twitter using #CatoHealth. Follow @CatoEvents on Twitter to get future event updates, live streams, and videos from the Cato Institute. If you have questions or need assistance registering for the event, please email our staff at events@cato.org.
Needle exchange programs are a proven means of reducing the spread of HIV and hepatitis among intravenous drug users. They are endorsed by the Centers for Disease Control and Prevention, the surgeon general of the United States, the World Health Organization, the American Public Health Association, and the American Medical Association. Nevertheless, needle exchange programs are legally permitted to operate in only 30 states and the District of Columbia. Drug paraphernalia laws make them illegal elsewhere.
Critics of needle exchange programs claim they “enable” or “endorse” illicit drug use. “Not‐in‐my‐backyard” attitudes fuel opposition in local communities. Experts will discuss the efficacy and role of this harm‐reduction strategy as well as the political challenges to its widespread adoption.
